Nebraska Lawmakers Advance Scaled-Back Medical Cannabis Commission Fixes With Unanimous Committee Support
LINCOLN — In a rare moment of consensus on medical marijuana policy, a key legislative panel unanimously advanced a scaled-back bill Tuesday aimed at making technical adjustments to the state’s newly formed cannabis regulatory body.
The eight-member General Affairs Committee voted to move forward an amended version of Legislative Bill 1235, a significantly trimmed proposal designed to address funding, staffing and operational gaps within the Nebraska Medical Cannabis Commission.
The revised legislation has been reduced to just three pages from its original 28 and focuses narrowly on administrative needs rather than broader regulatory expansion.
Among its provisions, the bill would:
- Provide salaries of $12,500 for the commission’s five members
- Establish a dedicated state cash fund for commission operations
- Allow the commission to charge application fees up to $50,000
- Require fingerprinting for license applicants
Supporters characterized the measure as modest but necessary groundwork as Nebraska’s voter-approved medical cannabis program continues to take shape.
Lawmakers Call Measure “A Small Step” Toward Functional Medical Cannabis Oversight
State Sen. John Cavanaugh of Omaha, the committee’s vice chair, emphasized that while the bill does not dramatically expand patient access, it avoids hindering progress.
“It doesn’t make really much progress in terms of getting us to where we need to be in providing available, accessible, safe medical cannabis, but it is not hurting that goal,” Cavanaugh said.
Following the vote, he added: “It’s a small step. At least it’s not a step backwards.”
The unanimous committee action marked a notable shift in tone for a Legislature that has often been divided over cannabis policy.
Addressing Funding Gaps and Administrative “Holes” After Voter Legalization
Committee chair Rick Holdcroft said technical fixes are common after voter-approved ballot measures create new state entities.
Nebraska voters established the Medical Cannabis Commission in November 2024 alongside legalizing possession of up to five ounces of medical cannabis with a healthcare provider’s recommendation.
Holdcroft said lawmakers quickly discovered practical challenges.
“After ballot measures are passed, there are typically a few holes that need to be filled,” he said, pointing specifically to funding mechanisms and fee authority.
The updated bill is intended to give the commission enough financial and administrative capacity to continue building the state’s medical cannabis framework.
“If down the road it looks like there’s something the Legislature needs to do, then we’ll take another look at it,” Holdcroft added.
Broader Regulatory Expansion Removed From Original Legislative Proposal
The initial version of LB 1235 went far beyond administrative fixes.
Introduced on behalf of the commission, it would have expanded regulatory authority over patients, providers and product testing facilities powers already partially granted through the ballot initiative.
It also proposed restrictions such as:
- Limiting medical cannabis recommendations to in-state physicians
- Requiring providers to register in a state directory
- Mandating annual cannabis education for recommending clinicians
- Requiring submission of patient data to regulators
These provisions drew sharp criticism from patient advocates and industry stakeholders, who warned they could restrict access and deter participation.
The committee ultimately replaced the broader proposal with the narrower administrative package now advancing.
Provider Protections Remain a Central Policy Debate
Access to medical cannabis recommendations remains a major concern in Nebraska.
Advocates say few healthcare providers have issued recommendations due to fear of professional discipline or legal exposure.
To address this, Sen. Cavanaugh has introduced separate legislation that would shield providers from criminal, civil or licensing penalties solely for recommending medical cannabis.
That proposal faces opposition from Mike Hilgers, who previously resisted similar protections during earlier legislative debates.
Commission Seeks Revenue Authority as Licensing Work Continues
Despite funding challenges, the commission has begun licensing parts of the industry.
So far, regulators have approved three cultivators and expect to license a fourth soon. Timelines for manufacturers, transporters and dispensaries remain under discussion.
Interim commission chair Lorelle Mueting has stressed the urgency of establishing revenue streams.
“There’s no medical cannabis state in this country that has no money to work with,” she said at a February meeting.
The new fee authority capped at $50,000 is designed to create operational sustainability without requiring frequent legislative intervention.
Holdcroft noted that commissioners are unlikely to impose the maximum fee immediately but want flexibility for future adjustments.
Confirmation Votes and Dual Roles Expand Commission Structure
Lawmakers also advanced confirmation votes for the commission’s three newest members.
The body includes:
- Two at-large appointees
- Three members drawn from the state Liquor Control Commission
Those liquor regulators, already earning $12,500 annually, would receive $25,000 for serving in dual roles if confirmed.
Patients and Families Opposed Earlier Version of Commission Bill
Public testimony revealed deep divisions over the original proposal.
Patients, caregivers and many industry advocates argued the earlier bill risked over-regulating access before the program even launched.
Some warned it would centralize too much authority within the commission and create barriers to care.
Michael Johnson, a cannabis executive with experience in western state markets, testified that the proposal risked constricting the industry.
“It’s strangling the industry before it gets off the ground,” he said.
Tribal leaders also raised concerns that strict registration and access rules could undermine alternative patient pathways, including services on sovereign tribal land.
Industry Groups Back Strong Regulatory Infrastructure
Not all stakeholders opposed the broader framework.
Nancy Laughlin-Wagner, CEO of Midwest Cultivators Group — the state’s first licensed cultivator — argued that robust oversight systems are essential before products reach patients.
“This bill establishes several critical operational infrastructures that must be in place before medical cannabis can be responsibly made available,” she testified.
Robert Wagner of the Nebraska Cannabis Trade Alliance echoed the need for regulatory clarity, saying stable rules are vital for long-term economic viability.
Debate Emerges Over Whether Commissioners Should Be Elected
Alongside LB 1235, lawmakers also considered a separate proposal that would fundamentally restructure commission governance.
A bill from Sen. Cavanaugh would convert appointed commission seats into elected positions.
Supporters say elections would improve accountability and align regulators more closely with voter intent.
But some committee members questioned whether altering the commission’s structure would contradict the ballot initiative approved by voters.
State Sen. Bob Andersen argued the change could conflict with what Nebraskans authorized at the ballot box.
Cavanaugh countered that elections could still honor voter “spirit” even if they altered implementation details.
The committee did not advance the election proposal Tuesday.
Legislative Friction Reflects Broader Cannabis Policy Tensions
The debate highlighted ongoing friction between lawmakers, regulators, patients and industry operators.
Some advocates argue the commission has been overly cautious and slow to implement access.
Others say strong guardrails are necessary for a program launching in a politically divided state.
Years of failed legislative attempts preceded the successful 2024 ballot initiative, adding to today’s policy tensions.
Priority Status Improves Bill’s Chances
The amended LB 1235 will receive a committee priority designation, increasing its likelihood of reaching the full legislative floor.
A more comprehensive cannabis framework failed last year by a single vote — 23-22 — far short of the 33 required to overcome a filibuster.
By narrowing the scope to administrative fixes, lawmakers appear to be pursuing incremental progress rather than sweeping reform.
For now, supporters say even modest movement matters.
As Sen. Cavanaugh put it: the bill may be small but at least it moves Nebraska’s medical cannabis system forward rather than backward.
Topic(s):
OG source Download Article 
